Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Last year it was reported that AstraZeneca was considering moving the manufacturing of its Covid-19 jab overseas amid a ...
Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...
GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
PhilStar Global on MSN23h
DTI: Cognizant, Maersk, other firms eye Philippines expansionInformation technology services firm Cognizant and transport and logistics firm A.P. Moller – Maersk are exploring investment opportunities in the Philippines, according to the Department of Trade and ...
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu is now approved to treat a new subset of breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback